Answer
Oct 23, 2025 - 11:05 AM
The maintenance dose used in clinical trials is 2.4 mg weekly, typically reached by week 17 through a dose-escalation protocol. Gradual dose escalation helps minimize side effects and improve tolerability.
Do you have the same question? Follow this Question
Oct 23, 2025 - 11:05 AM
View all Cagrilintide Questions & Answers